Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "CH Basel Balavenkatraman KK"

From Bioblast
Β 
(4 intermediate revisions by one other user not shown)
Line 6: Line 6:
|country=Switzerland
|country=Switzerland
|Contact=Balavenkatraman Kamal Kumar
|Contact=Balavenkatraman Kamal Kumar
|MiPNetLab=Grueninger S, Weiss A
|MiPNetLab=Grueninger Stephan
|Team previous=Chiesi M
|Team previous=Chiesi Michele, Weiss Alexander
|Status=O2k 2007 – Β 
|Status=O2k 2007 – Β 
|info=[http://oroboros.at/index.php?id=ioc39-schroecken IOC39]
|info=[[IOC106]], [[IOC39]]
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM]
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM]
}}
}}
* Previously CH_Basel_Chiesi M
* Previously CH_Basel_Chiesi M

Latest revision as of 11:39, 14 May 2019

                



CH Basel Balavenkatraman KK

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21
Address Klybeckstr 191, 4057
City Basel
State/Prov
Country Switzerland
Weblink
Contact Balavenkatraman Kamal Kumar
Team Grueninger Stephan
Team previous Chiesi Michele, Weiss Alexander
Status O2k 2007 –
Oroboros Events IOC106, IOC39
Topics


O2k-Publications

update please

O2k-Abstracts

update please

  • Previously CH_Basel_Chiesi M